Clinical Trial Update: Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating two pharmacologic strategies for HIV-associated neurocognitive impairment; the study is completed and reports on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hiv-associated Neurocognitive Disorder

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: Neurocognitive Disturbance, HIV Infection | Phase 4 | Status: COMPLETED